Back to Search
Start Over
Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease
- Publication Year :
- 2020
-
Abstract
- AIMS Experimental data suggest that visceral adipose tissue (VAT) dysfunction contributes to non-alcoholic fatty liver disease (NAFLD) development in obesity, however, data on humans are limited. Aims of this study were to investigate the relationship between NAFLD and VAT morphofunctional impairment and to determine whether the extent of VAT remodelling is associated with liver damage and metabolic alterations in obesity. METHODS We analysed data from 40 obese individuals candidate to bariatric surgery in whom paired intraoperative liver and omental biopsies were performed for diagnosing NAFLD and VAT inflammation by immunohistochemistry and mRNA expression studies. RESULTS Within our study population, NAFLD was significantly associated with greater VAT CD68+ macrophages infiltration (P = .04), fibrosis (P = .04) and impaired microvascular density (P = .03) as well as increased expression of markers of local hypoxia, apoptosis and inflammation (UNC5B, CASP7, HIF1-α, IL-8, MIP2, WISP-1, all P
- Subjects :
- medicine.medical_specialty
obesity
Endocrinology, Diabetes and Metabolism
Adipose tissue
030209 endocrinology & metabolism
Inflammation
030204 cardiovascular system & hematology
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Endocrinology
Non-alcoholic Fatty Liver Disease
Fibrosis
Internal medicine
Diabetes mellitus
NAFLD
Internal Medicine
medicine
Humans
adipose tissue
inflammation
CD68
business.industry
Fatty liver
Patient Acuity
nutritional and metabolic diseases
Hypoxia (medical)
medicine.disease
medicine.symptom
Steatosis
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....068dc1088a3fef97817013b6f80c6d52